bnP for pRediction of Outcome FollowIng Lung rEsection Surgery

  • Research type

    Research Study

  • Full title

    PROFILES: bnP for prediction of Outcome Following Lung resection Surgery

  • IRAS ID

    251030

  • Contact name

    Ben Shelley

  • Contact email

    Benjamin.Shelley@glasgow.ac.uk

  • Sponsor organisation

    National Waiting Times Centre Board

  • Duration of Study in the UK

    2 years, 0 months, 1 days

  • Research summary

    Lung cancer is the second most common type of cancer in the UK and is the leading cause of cancer related death. Where appropriate, surgery to remove the tumour and the surrounding lung(lung resection) provides the best chance of cure. Frequently patients are either current or ex- smokers with related lung or heart problems which increase the risks associated with surgery.
    Following surgery patients may suffer long term shortness of breath, greatly limiting their day-to-day function and lowering quality of life. Public engagement work that we have carried out demonstrates that second only to “being alive and cancer free” exercise capacity was the main priority of post-operative patients.
    We believe this post-operative shortness of breath is not solely caused by the removal of part of the lung but also from a decrease in the performance of the heart. Although the surgery does not directly involve the heart, it is thought that the damage is caused indirectly by the surgery and by removal of part of the lung. Our group is also working on better understanding the mechanisms of this heart injury. If it was possible to identify patients at increased risk of breathlessness following surgery, we believe there would be a window of opportunity in which we could intervene.
    Current methods for predicting breathlessness and quality of life after lung resection for cancer are inaccurate. Some patients are refused surgery on the basis of these who may otherwise have gone on to have successful surgery. At present there is no specific treatment for patients considered to be at increased risk of breathlessness.
    This study asks can BNP (B type-natriuretic peptide, a simple blood marker of heart strain) be used alongside current risk prediction to more accurately identify those at risk of breathlessness and poor quality of life after lung resection for lung cancer?

  • REC name

    London - Queen Square Research Ethics Committee

  • REC reference

    18/LO/1563

  • Date of REC Opinion

    13 Sep 2018

  • REC opinion

    Further Information Favourable Opinion